Literature DB >> 32108853

Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease.

Upasana Ganguly1, Anindita Banerjee1, Sankha Shubhra Chakrabarti2, Upinder Kaur2, Oishimaya Sen1, Roberto Cappai3, Sasanka Chakrabarti4.   

Abstract

The toxicity of accumulated α-synuclein plays a key role in the neurodegeneration of Parkinson's disease. This study has demonstrated that iron in varying concentrations (up to 400 µM) causes an increase in α-synuclein content in SH-SY5Y cells associated with mitochondrial depolarization, decreased cellular ATP content and loss of cell viability during incubation up to 96 h. Knocking-down α-synuclein expression prevents cytotoxic actions of iron, which can also be prevented by cyclosporine A (a blocker of mitochondrial permeability transition pore). These results indicate that iron cytotoxicity is mediated by α-synuclein acting on mitochondria. Likewise siRNA mediated knock-down of Parkin causes an  accumulation of  α-synuclein accompanied by mitochondrial dysfunction and cell death during 48 h incubation under basal conditions, but these changes are not further aggravated by co-incubation with  iron (400 µM). We have also analyzed mitochondrial dysfunction and cell viability in SH-SY5Y cells under double knock-down (α-synuclein and Parkin concurrently) conditions during incubation for 48 h with or without iron. Our results tend to suggest that iron inactivates Parkin in SH-SY5Y cells and thereby inhibits the proteasomal degradation of α-synuclein, and the accumulated α-synuclein causes mitochondrial dysfunction and cell death. These results have implications in the pathogenesis of sporadic Parkinson's disease and also familial type with Parkin mutations. Copyright 2020 The Author(s).

Entities:  

Keywords:  Cyclosporine A; Iron; Parkinsons disease; alpha synuclein; mitochondrial dysfunction; parkin

Year:  2020        PMID: 32108853     DOI: 10.1042/BCJ20190676

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  8 in total

1.  Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders.

Authors:  Shun Zhu; Fang Liu; Ruiyuan Zhang; Zongxiang Xiong; Qian Zhang; Li Hao; Shiyin Chen
Journal:  Front Pharmacol       Date:  2022-06-16       Impact factor: 5.988

Review 2.  Alpha-Synuclein as a Biomarker of Parkinson's Disease: Good, but Not Good Enough.

Authors:  Upasana Ganguly; Sukhpal Singh; Soumya Pal; Suvarna Prasad; Bimal K Agrawal; Reena V Saini; Sasanka Chakrabarti
Journal:  Front Aging Neurosci       Date:  2021-07-08       Impact factor: 5.750

3.  Brain Hepcidin Suppresses Major Pathologies in Experimental Parkinsonism.

Authors:  Tuo Liang; Zhong-Ming Qian; Ming-Dao Mu; Wing-Ho Yung; Ya Ke
Journal:  iScience       Date:  2020-06-19

4.  ATP13A2 protects dopaminergic neurons in Parkinson's disease: from biology to pathology.

Authors:  Tao Dang; Wen-Jing Cao; Rong Zhao; Ming Lu; Gang Hu; Chen Qiao
Journal:  J Biomed Res       Date:  2022-03-28

Review 5.  Targeting Molecular Mediators of Ferroptosis and Oxidative Stress for Neurological Disorders.

Authors:  Jing Li; Bowen Jia; Ying Cheng; Yiting Song; Qianqian Li; Chengliang Luo
Journal:  Oxid Med Cell Longev       Date:  2022-07-22       Impact factor: 7.310

6.  Neuroprotective effects of kukoamine A on 6-OHDA-induced Parkinson's model through apoptosis and iron accumulation inhibition.

Authors:  Xin Li; Xiao-Wen Jiang; Hai-Xiao Chu; Qing-Chun Zhao; Huai-Wei Ding; Chao-Hong Cai
Journal:  Chin Herb Med       Date:  2020-12-08

7.  Nilotinib in Parkinson's disease: A systematic review and meta-analysis.

Authors:  Xiaolu Xie; Ping Yuan; Liqiu Kou; Xiu Chen; Jun Li; Yaling Li
Journal:  Front Aging Neurosci       Date:  2022-09-29       Impact factor: 5.702

8.  A curious case of cysteines in human peroxiredoxin I.

Authors:  Ashu Mohammad; Reena V Saini; Rakesh Kumar; Deepak Sharma; Neeraj K Saini; Arpit Gupta; Priyanka Thakur; Christine C Winterbourn; Adesh K Saini
Journal:  Redox Biol       Date:  2020-09-24       Impact factor: 11.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.